{
  "id": 15640297,
  "title": "Landmark UK Biobank, IMU Immune Profiling Initiative Taps Ultima and Waters",
  "url": "https://urgent.news/2026/10/19/landmark-uk-biobank-imu-immune-profiling-initiative-taps-ultima-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T18:38:05.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/omics/landmark-uk-biobank-imu-immune-profiling-initiative-taps-ultima-and-waters/"
  },
  "original_language": "en",
  "account": null,
  "summary": "London-based IMU Biosciences has joined forces with the UK Biobank to create the most comprehensive and detailed map of the human immune system. By utilizing IMU's HD Immunology platform, Waters Corporation's flow cytometry and multiomic instrumentation, and Ultima Genomics' UG200 Sequencing Platform, the collaboration aims to generate over 100 million immune data points from tens of thousands of blood samples. The resulting dataset will add a new layer to UK Biobank's existing de-identified genomic, imaging, clinical, and lifestyle data, allowing researchers to study immune variation's relationship to disease risk, progression, treatment response, and long-term health outcomes.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}